SG10201803758XA - Enhanced Transgene Expression and Processing - Google Patents
Enhanced Transgene Expression and ProcessingInfo
- Publication number
- SG10201803758XA SG10201803758XA SG10201803758XA SG10201803758XA SG10201803758XA SG 10201803758X A SG10201803758X A SG 10201803758XA SG 10201803758X A SG10201803758X A SG 10201803758XA SG 10201803758X A SG10201803758X A SG 10201803758XA SG 10201803758X A SG10201803758X A SG 10201803758XA
- Authority
- SG
- Singapore
- Prior art keywords
- processing
- transgene expression
- expression
- enhanced transgene
- enhanced
- Prior art date
Links
- 108700019146 Transgenes Proteins 0.000 title abstract 2
- 241000288906 Primates Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/90—Vectors containing a transposable element
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361759802P | 2013-02-01 | 2013-02-01 | |
| US201361800244P | 2013-03-15 | 2013-03-15 | |
| US201361806634P | 2013-03-29 | 2013-03-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201803758XA true SG10201803758XA (en) | 2018-06-28 |
Family
ID=50239688
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201505487UA SG11201505487UA (en) | 2013-02-01 | 2014-02-01 | Enhanced transgene expression and processing |
| SG10201803758XA SG10201803758XA (en) | 2013-02-01 | 2014-02-01 | Enhanced Transgene Expression and Processing |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201505487UA SG11201505487UA (en) | 2013-02-01 | 2014-02-01 | Enhanced transgene expression and processing |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US11898154B2 (ru) |
| EP (2) | EP3536797B1 (ru) |
| JP (1) | JP6563816B2 (ru) |
| KR (1) | KR102235603B1 (ru) |
| CN (1) | CN105073995A (ru) |
| AU (2) | AU2014210856B2 (ru) |
| CA (1) | CA2898878C (ru) |
| DK (2) | DK3536797T3 (ru) |
| ES (2) | ES2940433T3 (ru) |
| FI (1) | FI3536797T3 (ru) |
| HK (1) | HK1216323A1 (ru) |
| HU (2) | HUE043103T2 (ru) |
| IL (1) | IL240198B (ru) |
| LT (1) | LT2951309T (ru) |
| PL (2) | PL2951309T3 (ru) |
| PT (2) | PT3536797T (ru) |
| RU (1) | RU2711505C9 (ru) |
| SG (2) | SG11201505487UA (ru) |
| SI (1) | SI2951309T1 (ru) |
| WO (1) | WO2014118619A2 (ru) |
| ZA (1) | ZA201506419B (ru) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104975009B (zh) * | 2014-04-01 | 2019-10-18 | 三生国健药业（上海）股份有限公司 | 一种新型的含mar核心片段的动物细胞表达载体 |
| CN105154473B (zh) * | 2015-09-30 | 2019-03-01 | 上海细胞治疗研究院 | 一种高效安全的转座子整合系统及其用途 |
| JP6871679B2 (ja) * | 2016-03-23 | 2021-05-12 | 国立大学法人 岡山大学 | 遺伝子発現用カセット及びその産生物 |
| WO2017061354A1 (ja) * | 2015-10-06 | 2017-04-13 | 国立大学法人 岡山大学 | 遺伝子発現用カセット及びその産生物 |
| JP2017070224A (ja) * | 2015-10-06 | 2017-04-13 | 国立大学法人 岡山大学 | 遺伝子発現用カセット及びその産生物 |
| JP7370702B2 (ja) | 2015-12-24 | 2023-10-30 | セレクシス エス．エー． | タンパク質製造用の改善された真核細胞およびそれらの作製方法 |
| ITUA20161610A1 (it) * | 2016-03-14 | 2017-09-14 | Angela Anna Messina | Composto peptidico farmacologicamente attivo, procedimento per la sua preparazione e suo uso. |
| EP3219800A1 (en) * | 2016-03-15 | 2017-09-20 | Max-Delbrück-Centrum Für Molekulare Medizin | A transposon-based transfection system for primary cells |
| EP3219803A1 (en) * | 2016-03-15 | 2017-09-20 | Max-Delbrück-Centrum für Molekulare Medizin | Enhanced sleeping beauty transposons, kits and methods of transposition |
| ES2938626T3 (es) * | 2016-05-03 | 2023-04-13 | Lonza Ag | Modulación del metabolismo de los lípidos para la producción de proteínas |
| JP7382138B2 (ja) | 2016-10-03 | 2023-11-16 | 第一三共株式会社 | Ｈｓｐａ５遺伝子のプロモーター |
| US11278570B2 (en) | 2016-12-16 | 2022-03-22 | B-Mogen Biotechnologies, Inc. | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods |
| KR102523318B1 (ko) | 2016-12-16 | 2023-04-18 | 비-모젠 바이오테크놀로지스, 인크. | 증진된 ｈＡＴ 패밀리 트랜스포존 매개 유전자 전달 및 연관된 조성물, 시스템, 및 방법 |
| WO2018224162A1 (en) * | 2017-06-09 | 2018-12-13 | Biontech Rna Pharmaceuticals Gmbh | Methods for characterizing loss of antigen presentation |
| WO2019066548A2 (ko) * | 2017-09-29 | 2019-04-04 | (주)벳바젠 | 심부전의 예방 또는 치료용 약학적 조성물 |
| CN109929839B (zh) * | 2017-12-18 | 2021-02-12 | 华东师范大学 | 拆分型单碱基基因编辑系统及其应用 |
| CN108504692B (zh) * | 2018-03-26 | 2021-07-23 | 安徽大学 | 一种基因敲除cho细胞株的构建方法及其在治疗性重组蛋白表达中的应用 |
| US20210214747A1 (en) * | 2018-05-18 | 2021-07-15 | Sorbonne Universite | Molecular tools and methods for transgene integration and their transposition dependent expression |
| WO2019246486A2 (en) | 2018-06-21 | 2019-12-26 | B-Mogen Biotechnologies, Inc. | ENHANCED hAT FAMILY TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS |
| RU2686102C1 (ru) * | 2018-08-07 | 2019-04-24 | Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) | Рекомбинантный вектор для создания плазмидных генетических конструкций, обладающих повышенной длительностью экспрессии целевых генов |
| US20210343368A1 (en) * | 2018-09-05 | 2021-11-04 | Max-Delbrück-Centrum Für Molekulare Medizin In Der Helmholtz-Gemeinschaft | Method for Engineering Synthetic Cis-Regulatory DNA |
| US20210380661A1 (en) * | 2018-10-16 | 2021-12-09 | Texas Tech University System | Method to Express, Purify, and Biotinylate Eukaryotic Cell-Derived Major Histocompatibility Complexes |
| WO2020084528A1 (en) | 2018-10-24 | 2020-04-30 | Selexis Sa | Expression systems, recombinant cells and uses thereof |
| EP3902910A1 (en) * | 2018-12-24 | 2021-11-03 | Selexis S.A. | Characterization and inactivation of endogenous retroviruses in chinese hamster ovary cells |
| US20220088158A1 (en) | 2019-01-23 | 2022-03-24 | Aceragen, Inc. | Method of ameliorating a pro-inflammatory immunophenotype in farber disease subjects by repeated administration of a recombinant human acid ceramidase |
| IT201900002321A1 (it) * | 2019-02-18 | 2020-08-18 | Univ Degli Studi Padova | Peptidi con attivita' antitumorale |
| TWI818166B (zh) * | 2019-03-27 | 2023-10-11 | 美商菲尼克斯組織修復公司 | 用於生產膠原蛋白7組合物之系統及方法 |
| CN110006866B (zh) * | 2019-04-16 | 2022-04-22 | 杭州迈尔德生物科技有限公司 | 一种阿片类活性物质的通用检测方法及其检测试剂盒 |
| WO2020228721A1 (en) * | 2019-05-13 | 2020-11-19 | Lin Mei Chun | Method and kit for monitoring cancer |
| WO2021069675A1 (en) * | 2019-10-10 | 2021-04-15 | The Regents Of The University Of California | Methods to stabilize mammalian cells |
| IL270306A (en) | 2019-10-30 | 2021-05-31 | Yeda Res & Dev | Prevention and treatment of pre-myeloid and myeloid malignancies |
| CN110863008B (zh) * | 2019-11-22 | 2020-10-16 | 昆明学院 | Mar序列调控弱启动子构建高效表达载体的方法 |
| US20230046668A1 (en) | 2019-12-24 | 2023-02-16 | Selexis S.A. | Targeted integration in mammalian sequences enhancing gene expression |
| CN111500629B (zh) * | 2020-04-17 | 2021-11-19 | 安徽中盛溯源生物科技有限公司 | 一种高表达层粘连蛋白-511变体的方法及其应用 |
| WO2021231569A1 (en) * | 2020-05-14 | 2021-11-18 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Dual promoter systems |
| US20220010332A1 (en) * | 2020-07-08 | 2022-01-13 | Neuracle Genetics Inc. | Intron fragments |
| CN113881703B (zh) * | 2021-10-11 | 2022-06-21 | 中国人民解放军军事科学院军事医学研究院 | 一种提高cho细胞同源重组效率的方法及其相关产品和应用 |
| CN116440269B (zh) * | 2022-01-10 | 2024-02-09 | 华中农业大学 | Slc35a1基因作为靶点在防治猪流行性腹泻病中的应用 |
| CN114958914B (zh) * | 2022-06-06 | 2023-09-26 | 新乡医学院 | 一种人类及哺乳动物细胞附着体表达载体、构建方法和应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5731178A (en) | 1990-03-21 | 1998-03-24 | Behringwerke Aktiengesellschaft | Attachment-elements for stimulation of eukaryotic expression systems |
| JP3656277B2 (ja) * | 1995-05-17 | 2005-06-08 | 味の素株式会社 | 組換えｄｎａ法によるトランスグルタミナーゼの効率的製造法 |
| ATE437233T1 (de) | 2001-01-26 | 2009-08-15 | Selexis Sa | Matrix-anheftungsregionen und verfahren zu deren verwendung |
| US20040235011A1 (en) * | 2002-06-26 | 2004-11-25 | Cooper Richard K. | Production of multimeric proteins |
| WO2004065581A2 (en) * | 2003-01-15 | 2004-08-05 | Discovery Genomics, Inc. | Transposon-insulator element delivery systems |
| US7244616B2 (en) * | 2003-06-27 | 2007-07-17 | Bayer Pharmaceuticals Corporation | Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
| WO2005040377A2 (en) | 2003-10-24 | 2005-05-06 | Selexis S.A. | High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences |
| ES2292271B1 (es) * | 2004-05-20 | 2009-02-16 | Proyecto De Biomedicina Cima, S.L. | Un vector hibrido adenovirus-alfavirus para la administracion eficaz y expresion de genes terapeuticos en celulas tumorales. |
| JP2008543283A (ja) * | 2005-06-10 | 2008-12-04 | ジェネンテック・インコーポレーテッド | インスレーターエレメントを含むベクターを使用する抗体発現の改良 |
| DK3156414T3 (da) * | 2007-09-26 | 2020-03-09 | Intrexon Corp | Syntetisk 5'utrs ekspressionsvektorer og fremgangsmåder til øgning af transgen ekspression |
| US20090247609A1 (en) | 2007-12-20 | 2009-10-01 | Hitto Kaufmann | Sm-protein based secretion engineering |
| US20100105140A1 (en) * | 2008-07-16 | 2010-04-29 | Fahrenkrug Scott C | Plaice dna transposon system |
| WO2010118360A1 (en) * | 2009-04-09 | 2010-10-14 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Production of proteins using transposon-based vectors |
| SG178940A1 (en) | 2009-09-18 | 2012-04-27 | Selexis Sa | Products and methods for enhanced transgene expression and processing |
-
2014
- 2014-02-01 EP EP19153376.9A patent/EP3536797B1/en active Active
- 2014-02-01 DK DK19153376.9T patent/DK3536797T3/da active
- 2014-02-01 CA CA2898878A patent/CA2898878C/en active Active
- 2014-02-01 WO PCT/IB2014/000100 patent/WO2014118619A2/en active Application Filing
- 2014-02-01 CN CN201480010305.9A patent/CN105073995A/zh active Pending
- 2014-02-01 ES ES19153376T patent/ES2940433T3/es active Active
- 2014-02-01 HU HUE14708935A patent/HUE043103T2/hu unknown
- 2014-02-01 DK DK14708935.3T patent/DK2951309T3/en active
- 2014-02-01 EP EP14708935.3A patent/EP2951309B1/en active Active
- 2014-02-01 US US14/761,460 patent/US11898154B2/en active Active
- 2014-02-01 JP JP2015555816A patent/JP6563816B2/ja active Active
- 2014-02-01 HU HUE19153376A patent/HUE061494T2/hu unknown
- 2014-02-01 PL PL14708935T patent/PL2951309T3/pl unknown
- 2014-02-01 ES ES14708935T patent/ES2717175T3/es active Active
- 2014-02-01 LT LTEP14708935.3T patent/LT2951309T/lt unknown
- 2014-02-01 FI FIEP19153376.9T patent/FI3536797T3/fi active
- 2014-02-01 PT PT191533769T patent/PT3536797T/pt unknown
- 2014-02-01 PT PT14708935T patent/PT2951309T/pt unknown
- 2014-02-01 PL PL19153376.9T patent/PL3536797T3/pl unknown
- 2014-02-01 KR KR1020157022393A patent/KR102235603B1/ko active IP Right Grant
- 2014-02-01 SG SG11201505487UA patent/SG11201505487UA/en unknown
- 2014-02-01 SI SI201431115T patent/SI2951309T1/sl unknown
- 2014-02-01 RU RU2015127667A patent/RU2711505C9/ru active
- 2014-02-01 SG SG10201803758XA patent/SG10201803758XA/en unknown
- 2014-02-01 AU AU2014210856A patent/AU2014210856B2/en active Active
-
2015
- 2015-07-28 IL IL24019815A patent/IL240198B/en active IP Right Grant
- 2015-09-01 ZA ZA2015/06419A patent/ZA201506419B/en unknown
-
2016
- 2016-04-14 HK HK16104299.2A patent/HK1216323A1/zh unknown
-
2019
- 2019-10-18 AU AU2019250224A patent/AU2019250224B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201803758XA (en) | Enhanced Transgene Expression and Processing | |
| IL261979A (en) | A mammalian cell line for protein production and a breeding library | |
| HK1248755A1 (zh) | 主要造血細胞中的蛋白質傳遞 | |
| IL261665A (en) | Production of avv in insect cells, methods and preparations thereof | |
| HK1243332A1 (zh) | 改變在修飾的t細胞中的基因表達及其用途 | |
| HK1214304A1 (zh) | 用於在細胞中表達蛋白質的方法和產品 | |
| MX2017006802A (es) | Animales no humanos que expresan el complejo cd3 humanizado. | |
| EP3353280A4 (en) | MASS LABEL ANALYSIS FOR RARE CELLS AND MOLECULES WITHOUT CELLS | |
| EP3325698A4 (en) | CELL CULTURE, TRANSPORT AND INVESTIGATION | |
| EP3701045A4 (en) | IMPROVEMENTS TO OR RELATING TO CELLAL ANALYSIS | |
| EP3237613A4 (en) | Visualizing modified nucleotides and nucleic acid interactions in single cells | |
| EP3365452C0 (en) | EXPRESSION IN MAMMAL CELLS USING GAUSSIA LUCIFERASE SIGNAL PEPTIDES | |
| EP3072953A4 (en) | Cell culture container and container in which cell culture has been accommodated | |
| IL247491A0 (en) | Expression constructs and methods for selecting host cells expressing polypeptides | |
| EP3191578A4 (en) | Cells expressing apolipoprotein e and uses thereof | |
| EP3332036A4 (en) | GENETIC ANOMALIES IN PLASMA CELL DYSCRASIES | |
| EP3164148A4 (en) | Methods and compositions for inhibiting growth and epithelial to mesenchymal transition (emt) in cancer cells | |
| MX2020012356A (es) | Sobreexpresion de reguladores de la ruta de n-glicosilacion para modular la glicosilacion de proteinas recombinantes. | |
| EP3321351A4 (en) | Cell-holding container and cell culture method using same | |
| GB201113499D0 (en) | Expression of transcription factor encoding genes | |
| IL269252A (en) | Expression constructs and methods for expressing polypeptides in eukaryotic cells | |
| MY198268A (en) | Omega-hydroxylase-related fusion polypeptides with improved properties | |
| ES2523016A1 (es) | Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes | |
| MX2016005572A (es) | Uso de monensina para regular la glicosilacion de proteinas recombinantes. | |
| GB201403522D0 (en) | Improvements in and relating to processed biological sample storage |